Investigating the impact of arsenic and other metals in drinking water on cancer in the San Carlos Apache community
Arsenic and other co-metals in the San Carlos Apache drinking water
This study is looking at how drinking water with arsenic and other metals might affect cancer rates in the San Carlos Apache community, and it aims to help people understand their health risks better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10915593 on NIH RePORTER |
What this research studies
This research focuses on understanding how exposure to arsenic and other co-metals in drinking water affects cancer outcomes among the San Carlos Apache community in Arizona. The study will analyze historical water quality data and assess the relationship between these contaminants and various types of cancer, including bladder, breast, and lung cancers. Researchers will develop an exposure assessment tool to help identify high-risk areas and provide valuable information to the community. The findings aim to empower tribal members and leaders with knowledge about environmental health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research are members of the San Carlos Apache community who have been exposed to contaminated drinking water.
Not a fit: Patients who do not reside in the San Carlos Apache reservation or have not been exposed to the specific contaminants studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and targeted interventions for cancer prevention in the Apache community.
How similar studies have performed: Previous research has shown that assessing environmental contaminants can significantly impact public health, indicating potential success for this approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Samuel-Nakamura, Christine — University of California Los Angeles
- Study coordinator: Samuel-Nakamura, Christine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.